Cardiac resynchronisation therapy

Summary

Aim: Cardiac resynchronisation therapy (CRT) has been shown to improve haemodynamics and clinical symptoms in heart failure patients. The present study evaluated the effects of a 4-month CRT on myocardial blood flow (MBF) at rest, after vasodilation and on myocardial oxygen consumption (MVO₂). Patients, Methods: We studied 16 patients with idiopathic dilated cardiomyopathy prior to and during CRT performed as biventricular pacing. Resting MBF and MVO₂ were determined from an 11C-acetate PET study and vasodilator MBF from a 13N-ammonia study. Results: MBF at rest (0.55 ± 0.10 ml/min/g), after vasodilation (1.20 ± 0.45 ml/min/g), and MVO₂ (0.082 ± 0.014/min) did not change by mid-term CRT at a global level (0.57 ± 0.11 ml/min/g; 1.32 ± 0.49 ml/min/g; 0.085 ± 0.018/min), whereas the rate pressure product (RPP) normalised MVO₂ decreased from 0.104 ± 0.024 to 0.086 ± 0.018/min (p = 0.02). At baseline, the regional analysis revealed significantly higher values for all parameters in the lateral wall than for those in the other walls. Under CRT the regional differences between the resting parameters equalised and all parameters showed significant lower coefficients of variation. Conclusion: Effects of mid-term CRT on resting MBF, vasodilator MBF and MVO₂ occur at a regional level. The resynchronisation is associated with a more homogenous distribution pattern of these parameters among the myocardial walls. Substantial alterations to global MBF at rest, after vasodilation or to MVO₂ are not detectable. Regarding the RPP normalised MVO₂, there is evidence of improved ventricular efficiency through CRT.

Zusammenfassung

Ziel: Bei Patienten mit chronischer Herzinsuffizienz können durch eine kardiale Resynchronisationstherapie (CRT) Hämodynamik und klinische Symptomatik gebessert werden. Die vorliegende Studie untersuchte die Auswirkungen einer 4monatigen CRT auf den myokardialen Blutfluss (MBF) in Ruhe, unter Vasodilatation sowie auf den myokardialen Sauerstoffverbrauch (MVO₂). Patienten, Methoden: Bei 16 Patienten mit idiopathischer dilatativer Kardiomyopathie vor und während biventrikulärer CRT. MBF und MVO₂ im Ruhezustand wurden mittels 11C-Acetat PET und MBF unter Vasodilatation mittels 13N-Ammoniak PET bestimmt. Ergebnisse: Der globale MBF in Ruhe (0,55 ± 0,10 ml/min/g), unter Vasodilatation (1,20 ± 0,45 ml/ min/g) und der MVO₂ (0,082 ± 0,014/min) änderten sich während der CRT nicht (0,57 ± 0,11 ml/min/g; 1,32 ± 0,49 ml/min/g; 0,085 ± 0,018/min). Der auf das Blutdruck-Frequenz-Produkt (RPP) normalisierte MVO₂ sank von 0,104 ± 0,024 auf 0,086 ± 0,018/min (p = 0,02). Die regionale Auswertung ergab für alle Parameter vor der CRT in der Lateralwand signifikant höhere Werte als in den anderen Wänden. Durch die CRT glichen sich bei den Ruhewerten die Unterschiede aus. Alle Parameter wiesen signifikant niedrigere Variationskoeffizienten auf. Schlussfolgerungen: Auf regionaler Ebene zeigen sich Auswirkungen einer CRT auf den MBF in Ruhe und unter Vasodilatation sowie auf den MVO₂ in Form einer geringeren Variabilität der Parameter im Myokard. Grundsätzliche Änderungen des globalen MBF in Ruhe, unter Vasodilatation und des MVO₂ ergeben sich nicht. Betrachtet man den RPP-normalisierten MVO₂, weist dieser auf eine bessere Effizienz des Ventrikels durch die CRT hin.

Keywords

Heart failure - left bundle branch block - perfusion - oxygen consumption - PET

Schlüsselwörter

Herzinsuffizienz - Linksschenkelblock - Perfusion - Sauerstoffverbrauch - PET

• References

• 1 Hochleitner M, Hortnagl H, Ng CK. et al. Usefulness of physiologic dual-chamber pacing in drugresistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66: 198-202.
• 2 Saxon LA, Kerwin WF, Cahalan MK. et al. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol 1998; 9: 13-21.
• 3 Ukkonen H, Beanlands RS, Burwash IG. et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003; 107: 28-31.
• 4 Sundell J, Engblom E, Koistinen J. et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 2004; 43: 1027-33.
• 5 St John Sutton MG, Plappert T, Abraham WT. et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107: 1985-90.
• 6 Vogt J, Heintze J, Lamp B, Hansky B, Horstkotte D. Standard hemodynamic measurements. Eur Heart J 2004; (Suppl D): D91-D7.
• 7 van den Hoff J, Burchert W, Borner AR. et al. [1-11C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med 2001; 42: 1174-82.
• 8 Hutchins GD, Schwaiger M, Rosenspire KC. et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990; 15: 1032-42.
• 9 Knaapen P, van Campen LM, de Cock CC. et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 2004; 110: 646-51.
• 10 Nowak B, Sinha AM, Schaefer WM. et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003; 41: 1523-8.
• 11 Nowak B, Stellbrink C, Sinha AM. et al. Effects of cardiac resynchronization therapy on myocardial blood flow measured by oxygen-15 water positron emission tomography in idiopathic-dilated car- diomyopathy and left bundle branch block. Am J Cardiol 2004; 93: 496-9.
• 12 Parodi O, De Maria R, Oltrona L. et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 1993; 88: 509-22.
• 13 van den Heuvel AF, van Veldhuisen DJ, van der Wall EE. et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2000; 35: 19-28.
• 14 Uren NG, Melin JA, De Bruyne B. et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994; 330: 1782-8.
• 15 Beanlands RS, Bach DS, Raylman R. et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol 1993; 22: 1389-98.
• 16 Baller D, Schenk H, Strauer BE. et al. Comparison of myocardial oxygen consumption indices in man. Clin Cardiol 1980; 3: 116-22.
• 17 Prinzen FW, Hunter WC, Wyman BT. et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999; 33: 1735-42.
• 18 Wuesten B. Biophysics of myocardial perfusion. In: Schaper W. ed. The pathophysiology of myocardial perfusion. Amsterdam, New York, Oxford: Elsevier/North-Holland Biomedical Press; 1979: 199-244.
• 19 Grines CL, Bashore TM, Boudoulas H. et al. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation 1989; 79: 845-53.